Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis

Annals of the American Thoracic Society

Volumn 11, Issue 1, 2014, Pages 36-44

  Martiniano, Stacey L ^a   Sontag, Marci K ^b   Daley, Charles L ^c   Nick, Jerry A ^c   Sagel, Scott D ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Global Health and Health Disparities   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Mycobacterium abscessus; Mycobacterium avium complex; Nontuberculous mycobacteria

Indexed keywords

AZITHROMYCIN; MACROLIDE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIUM CULTURE; BODY MASS; CHILD; COMORBIDITY; CYSTIC FIBROSIS; DISEASE COURSE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG LAVAGE; MAJOR CLINICAL STUDY; MIXED INFECTION; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PERSISTENT INFECTION; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX RATIO; SPUTUM; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; TREATMENT RESPONSE; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; COINFECTION; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; NONTUBERCULOUS MYCOBACTERIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84893458487     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201309-310OC     Document Type: Article

References (42)

1. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, Brown-Elliot BA, Handler A, Wilson RW, Schechter MS, et al.; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828-834. (Pubitemid 36801769)
2. Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, Aviram M, Rivlin J, Picard E, Lavy A, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 2008;14:378-384. (Pubitemid 351451383)
3. Roux AL, Catherinot E, Ripoll F, Soismier N, Macheras E, Ravilly S, Bellis G, Vibet MA, Le Roux E, Lemonnier L, et al.; Jean-Louis Herrmann for the OMA Group. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol 2009;47:4124-4128.
4. Pierre-Audigier C, Ferroni A, Sermet-Gaudelus I, Le Bourgeois M, Offredo C, Vu-Thien H, Fauroux B, Mariani P, Munck A, Bingen E, et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 2005;43:3467-3470. (Pubitemid 40981368)
5. Sermet-Gaudelus I, Le Bourgeois M, Pierre-Audigier C, Offredo C, Guillemot D, Halley S, Akoua-Koffi C, Vincent V, Sivadon-Tardy V, Ferroni A, et al. Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis 2003;9:1587-1591. (Pubitemid 37505455)
6. Radhakrishnan DK, Yau Y, Corey M, Richardson S, Chedore P, Jamieson F, Dell SD. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatr Pulmonol 2009;44:1100-1106.
7. Esther CR, Jr., Esserman DA, Gilligan P, Kerr A, Noone PG. Chronic mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 2010;9:117-123.
8. Aitken ML, Burke W, McDonald G, Wallis C, Ramsey B, Nolan C. Nontuberculous mycobacterial disease in adult cystic fibrosis patients. Chest 1993;103:1096-1099. (Pubitemid 23110278)
9. Valenza G, Tappe D, Turnwald D, Frosch M, Konig C, Hebestreit H, Abele-Horn M. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros 2008;7:123-127. (Pubitemid 351372763)
10. Nick JA. Nontuberculous mycobacteria in cystic fibrosis. Semin Respir Crit Care Med 2003;24:693-702. (Pubitemid 38036764)
11. Bange FC, Brown BA, Smaczny C, Wallace RJ Jr, Böttger EC. Lack of transmission of mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin Infect Dis 2001;32: 1648-1650. (Pubitemid 32458737)
12. Oliver A, Maiz L, Cantón R, Escobar H, Baquero F, Gómez-Mampaso E. Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis 2001;32:1298-1303.
13. Fauroux B, Delaisi B, Clément A, Saizou C, Moissenet D, Truffot-Pernot C, Tournier G, Vu Thien H. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J 1997;16: 354-358.
14. Kilby JM, Gilligan PH, Yankaskas JR, Highsmith WE Jr, Edwards LJ, Knowles MR. Nontuberculous mycobacteria in adult patients with cystic fibrosis. Chest 1992;102:70-75.
15. Girón RM, Máiz L, Barrio I, Martínez MT, Salcedo A, Prados C. [Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study]. Arch Bronconeumol 2008; 44:679-684.
16. Hjelte L, Petrini B, Källenius G, Strandvik B. Prospective study of mycobacterial infections in patients with cystic fibrosis. Thorax 1990;45:397-400. (Pubitemid 20184900)
17. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, et al.; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175: 367-416. (Pubitemid 46271561)
18. Ballarino GJ, Olivier KN, Claypool RJ, Holland SM, Prevots DR. Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. Respir Med 2009;103: 1448-1455.
19. Martiniano SL, Sontag MK, Nick JA, Sagel SD. Nontuberculous mycobacterial infection in cystic fibrosis patients at a large CF care center [abstract]. Am J Respir Crit Care Med 2011;183:A2398.
20. Martiniano SL, Sontag MK, Nick JA, Sagel SD. Nontuberculous mycobacterial infection in cystic fibrosis patients at the Colorado CF care center [abstract]. Pediatr Pulmonol Suppl 2011;34:A255.
21. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187. (Pubitemid 29036522)
22. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, Ramsey BW, Clausen CR. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis 1998;27: 158-163. (Pubitemid 28334435)
23. Kobashi Y, Matsushima T, Oka M. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med 2007;101: 130-138. (Pubitemid 44835234)
24. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Koh WJ. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med 2009;180:896-902.
25. Koh WJ, Jeon K, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Shin SJ, Huitt GA, et al . Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011;183:405-410.
26. Esther CR Jr, Henry MM, Molina PL, Leigh MW. Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol 2005;40:39-44. (Pubitemid 40917906)
27. Torrens JK, Dawkins P, Conway SP, Moya E. Non-tuberculous mycobacteria in cystic fibrosis. Thorax 1998;53:182-185. (Pubitemid 28172368)
28. Olivier KN, Weber DJ, Lee JH, Handler A, Tudor G, Molina PL, Tomashefski J, Knowles MR; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria: II. Nested-cohort study of impact on cystic fibrosis lung disease. Am J Respir Crit Care Med 2003;167:835-840. (Pubitemid 36801770)
29. Catherinot E, Roux AL, Vibet MA, Bellis G, Ravilly S, Lemonnier L, Le Roux E, Bernède-Bauduin C, Le Bourgeois M, Herrmann JL, et al.; OMA group. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros 2013;12:74-80.
30. Esther CR Jr, Esserman DA, Gilligan P, Kerr A, Noone PG. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 2010;9:117-123.
31. Jönsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol 2007;45:1497-1504.
32. Cullen AR, Cannon CL, Mark EJ, Colin AA. Mycobacterium abscessus infection in cystic fibrosis: colonization or infection? Am J Respir Crit Care Med 2000;161:641-645. (Pubitemid 30129479)
33. Greendyke R, Byrd TF. Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria. Antimicrob Agents Chemother 2008;52:2019-2026. (Pubitemid 351758538)
34. Catherinot E, Clarissou J, Etienne G, Ripoll F, Emile JF, Daffé M, Perronne C, Soudais C, Gaillard JL, Rottman M. Hypervirulence of a rough variant of the Mycobacterium abscessus type strain. Infect Immun 2007;75:1055-1058. (Pubitemid 46203473)
35. Catherinot E, Roux AL, Macheras E, Hubert D, Matmar M, Dannhoffer L, Chinet T, Morand P, Poyart C, Heym B, et al. Acute respiratory failure involving an R variant of Mycobacterium abscessus. J Clin Microbiol 2009;47:271-274.
36. Mussaffi H, Rivlin J, Shalit I, Ephros M, Blau H. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 2005;25:324-328. (Pubitemid 40246534)
37. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 2011; 52:565-571.
38. Lam PK, Grif fith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;173:1283-1289. (Pubitemid 43848401)
39. Renna M, Schaffner C, Brown K, Shang S, Tamayo MH, Hegyi K, Grimsey NJ, Cusens D, Coulter S, Cooper J, et al. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest 2011;121:3554-3563.
40. Catherinot E, Roux AL, Vibet MA, Bellis G, Lemonnier L, Le Roux E, Bernede-Bauduin C, Le Bourgeois M, Herrmann JL, Guillemot D, et al. Inhaled therapies, azithromycin and mycobacterium abscessus in cystic fibrosis patients. Eur Respir J 2013;41:1101-1106.
41. Binder AM, Adjemian J, Olivier KN, Prevots DR. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med 2013;188:807-812.
42. Koh WJ, Jeong BH, Jeon K, Lee NY, Lee KS, Woo SY, Shin SJ, Kwon OJ. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease. Chest 2012;142:1482-1488.